Menu Back toQuantifying-the-Impact-of-Credentialed-Clinical-Research-Site-Professionals-on-Clinical-Trial-Conduct-Quality

DIA 2018 Global Annual Meeting


Quantifying the Impact of Credentialed Clinical Research Site Professionals on Clinical Trial Conduct Quality

    Session Chair(s)
      James  Kremidas

      James Kremidas

      • Executive Director
      • Association of Clinical Research Professionals (ACRP), United States
    In this session, representatives from the Association of Clinical Research Professionals (ACRP) and the Tufts Center for the Study of Drug Development (Tufts CSDD) will present novel data quantifying the impact of properly trained and credentialed – or “certified” – site professionals as it pertains to quality outcomes in clinical trial studies. Based on a joint ACRP/Tufts CSDD global survey this session will present key findings on: • Whether properly trained and credentialed site staff have any impact to trial quality performance factors such as reduced levels of protocol deviations, queries, monitoring visits, audit findings, non-enrolling sites, etc. • Whether credentialed site staff have any impact to staff productivity factors such as job satisfaction and reduced levels of turnover rates, etc.
    Learning Objective : Describe the growing need and importance to ensure quality performance of clinical research site staff; Discuss the impact of properly trained and credentialed professionals on clinical trial quality; Describe industry initiatives designed to enhance the quality and competency of clinical research site staff.
    Speaker(s)
      Beth D. Harper, MBA

      Update on Quantifying the Impact of Credentialed Clinical Research Site Professionals on Clinical Trial Conduct Quality

      Beth D. Harper, MBA

      • Workforce Innovation Officer
      • Association of Clinical Research Professionals, United States
      Kenneth A. Getz, DIAFellow, MBA

      To be determined

      Kenneth A. Getz, DIAFellow, MBA

      • Director of Sponsored Research Programs and Associate Professor
      • Center For the Study of Drug Development, Tufts University School of Medicine, United States